Vaccines2022; 10(3); 398; doi: 10.3390/vaccines10030398

Equids’ Core Vaccines Guidelines in North America: Considerations and Prospective.

Abstract: Vaccination against infectious diseases is a cornerstone of veterinary medicine in the prevention of disease transmission, illness severity, and often death in animals. In North American equine medicine, equine vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile are core vaccines as these have been classified as having a heightened risk of mortality, infectiousness, and endemic status. Some guidelines differ from the label of vaccines, to improve the protection of patients or to decrease the unnecessary administration to reduce potential side effects. In North America, resources for the equine practitioners are available on the American Association of Equine Practitioners (AAEP) website. Conversely, in small companion animals, peer review materials are regularly published in open access journals to guide the vaccination of dogs and cats. The aims of this review are to present how the vaccine guidelines have been established for small companion animals and horses in North America, to review the equine literature to solidify or contrast the current AAEP guidelines of core vaccines, and to suggest future research directions in the equine vaccine field considering small companion animal strategies and the current available resources in equine literature.
Publication Date: 2022-03-04 PubMed ID: 35335029PubMed Central: PMC8955191DOI: 10.3390/vaccines10030398Google Scholar: Lookup
The Equine Research Bank provides access to a large database of publicly available scientific literature. Inclusion in the Research Bank does not imply endorsement of study methods or findings by Mad Barn.
  • Journal Article
  • Review

Summary

This research summary has been generated with artificial intelligence and may contain errors and omissions. Refer to the original study to confirm details provided. Submit correction.

The article reviews the guidelines around core vaccines for horses in North America and discusses potential research directions, drawing upon strategies used in small companion animal vaccination.

Research Background

  • The research focuses on veterinary medicine, specifically vaccination against infectious diseases.
  • The main emphasis is on equine medicine, with core vaccines protecting against tetanus, rabies, Eastern and Western equine encephalomyelitis, and West Nile.
  • This is a preventive measure against diseases with high mortality rates, infectiousness, and endemic status.

Scope of the Research

  • The paper evaluates the guidelines concerning vaccines in North America.
  • It mentions that while some guidelines deviate from the vaccine labels to enhance protection or minimize unnecessary administration, the overall motive is to reduce potential side effects.
  • These guidelines and resources for equine practitioners are available on the American Association of Equine Practitioners (AAEP) website.
  • Among small companion animals like dogs and cats, peer-reviewed materials are openly published for guiding vaccination practices.

Aims and Objectives of the Research

  • The primary objectives of this research include offering insights into the establishment of vaccine guidelines for small companion animals and horses in North America.
  • It also reviews the current equine literature to validate or contrast the existing AAEP guidelines about core vaccines.
  • Lastly, the research aims to propose potential future research directions in the equine vaccine field, integrating strategies used for small companion animals and the resource availability as per current equine literature.

Cite This Article

APA
Desanti-Consoli H, Bouillon J, Chapuis RJJ. (2022). Equids’ Core Vaccines Guidelines in North America: Considerations and Prospective. Vaccines (Basel), 10(3), 398. https://doi.org/10.3390/vaccines10030398

Publication

ISSN: 2076-393X
NlmUniqueID: 101629355
Country: Switzerland
Language: English
Volume: 10
Issue: 3
PII: 398

Researcher Affiliations

Desanti-Consoli, Hu00e9lu00e8ne
  • DoctoraDesanti, San Jose 11801, Costa Rica.
Bouillon, Juliette
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis.
Chapuis, Ronan J J
  • Department of Clinical Sciences, Ross University School of Veterinary Medicine, P.O. Box 334, Basseterre, Saint Kitts and Nevis.

Conflict of Interest Statement

The authors declare no conflict of interest.

References

This article includes 84 references
  1. Aida V, Pliasas VC, Neasham PJ, North JF, McWhorter KL, Glover SR, Kyriakis CS. Novel Vaccine Technologies in Veterinary Medicine: A Herald to Human Medicine Vaccines.. Front Vet Sci 2021;8:654289.
    doi: 10.3389/fvets.2021.654289pmc: PMC8083957pubmed: 33937377google scholar: lookup
  2. Cohen N.D., Bordin A.I. Equine Clinical Immunology. John Wiley & Sons, Inc.; Chichester, UK: 2015. Principles of vaccination; pp. 263u2013278.
  3. Wilson J. Vaccine efficacy and controversies; Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners; Seattle, WA, USA. 3u20137 December 2005; pp. 409u2013420.
  4. Barros T., Moran G., Uberti B. Reactive Seizures After Vaccination in a Thoroughbred Broodmare. J. Equine Vet. Sci. 2019;73:106u2013109. doi: 10.1016/j.jevs.2018.12.004.
  5. American Association of Equine Practitioners (AAEP) Vaccination Guidelines. [(accessed on 26 December 2021)]. Available online: https://aaep.org/guidelines/vaccination-guidelines.
  6. Wilson W. Strategies for vaccinating mares, foals, and weanlings; Proceedings of the 51st Annual Convention of the American Association of Equine Practitioners; Seattle, WA, USA. 3u20137 December 2005; pp. 421u2013438.
  7. Stone AE, Brummet GO, Carozza EM, Kass PH, Petersen EP, Sykes J, Westman ME. 2020 AAHA/AAFP Feline Vaccination Guidelines.. J Feline Med Surg 2020 Sep;22(9):813-830.
    doi: 10.5326/JAAHA-MS-7123pubmed: 32845224google scholar: lookup
  8. Ford RB, Larson LJ, McClure KD, Schultz RD, Welborn LV. 2017 AAHA Canine Vaccination Guidelines.. J Am Anim Hosp Assoc 2017 Sep Oct;53(5):243-251.
    doi: 10.5326/JAAHA-MS-6741pubmed: 28846453google scholar: lookup
  9. Bittle JL, Grant WA, Scott FW. Canine and feline immunization guidelines--1982.. J Am Vet Med Assoc 1982 Aug 15;181(4):332-5.
    pubmed: 7118707
  10. Gumley N. Revaccination guidelines revisited.. Can Vet J 2000 Jan;41(1):26-7.
    pmc: PMC1476348pubmed: 10642869
  11. Klingborg DJ, Hustead DR, Curry-Galvin EA, Gumley NR, Henry SC, Bain FT, Paul MA, Boothe DM, Blood KS, Huxsoll DL, Reynolds DL, Riddell MG Jr, Reid JS, Short CR. AVMA Council on Biologic and Therapeutic Agents' report on cat and dog vaccines.. J Am Vet Med Assoc 2002 Nov 15;221(10):1401-7.
    doi: 10.2460/javma.2002.221.1401pubmed: 12458607google scholar: lookup
  12. American Veterinary Medical Association Vaccination Principles. [(accessed on 26 December 2021)]. Available online: https://www.avma.org/resources-tools/avma-policies/vaccination-principles.
  13. Paul MA, Appel M, Barrett R, Carmichael LE, Childers H, Cotter S, Davidson A, Ford R, Keil D, Lappin M, Schultz RD, Thacker E, Trumpeter JL, Welborn L. Report of the American Animal Hospital Association (AAHA) Canine Vaccine Task Force: executive summary and 2003 canine vaccine guidelines and recommendations.. J Am Anim Hosp Assoc 2003 Mar-Apr;39(2):119-31.
    pubmed: 12617540
  14. Day MJ, Horzinek MC, Schultz RD, Squires RA. WSAVA Guidelines for the vaccination of dogs and cats.. J Small Anim Pract 2016 Jan;57(1):E1-E45.
    doi: 10.1111/jsap.2_12431pmc: PMC7166872pubmed: 26780857google scholar: lookup
  15. American Animal Hospital Association (AAHA) Lifestyle-Based Vaccine Calculator. [(accessed on 26 December 2021)]. Available online: https://www.aaha.org/aaha-guidelines/2020-aahaaafp-feline-vaccination-guidelines/feline-vaccine-calculator/
  16. Wilson W.D., Pusterla N., Long D.C. Immunoprophylaxis. In: Sellon D.C., Long M.T., editors. Equine Infectious Diseases. 2nd ed. Elsevier Health Sciences; Saint Louis, MO, USA: 2013.
  17. Broaddus CC, Balasuriya UB, White JL, Timoney PJ, Funk RA, Holyoak GR. Evaluation of the safety of vaccinating mares against equine viral arteritis during mid or late gestation or during the immediate postpartum period.. J Am Vet Med Assoc 2011 Mar 15;238(6):741-50.
    doi: 10.2460/javma.238.6.741pubmed: 21401431google scholar: lookup
  18. Hooker B, Kern J, Geier D, Haley B, Sykes L, King P, Geier M. Methodological issues and evidence of malfeasance in research purporting to show thimerosal in vaccines is safe.. Biomed Res Int 2014;2014:247218.
    doi: 10.1155/2014/247218pmc: PMC4065774pubmed: 24995277google scholar: lookup
  19. Davis EG, Bello NM, Bryan AJ, Hankins K, Wilkerson M. Characterisation of immune responses in healthy foals when a multivalent vaccine protocol was initiated at age 90 or 180 days.. Equine Vet J 2015 Nov;47(6):667-74.
    doi: 10.1111/evj.12350pubmed: 25205445google scholar: lookup
  20. Pusterla N, Collier J, Mapes SM, Wattanaphasak S, Gebhart C. Effects of administration of an avirulent live vaccine of Lawsonia intracellularis on mares and foals.. Vet Rec 2009 Jun 20;164(25):783-5.
    doi: 10.1136/vr.164.25.783pubmed: 19542553google scholar: lookup
  21. Cauchard J, Sevin C, Ballet JJ, Taouji S. Foal IgG and opsonizing anti-Rhodococcus equi antibodies after immunization of pregnant mares with a protective VapA candidate vaccine.. Vet Microbiol 2004 Nov 30;104(1-2):73-81.
    doi: 10.1016/j.vetmic.2004.09.006pubmed: 15530741google scholar: lookup
  22. Martens R., Martens J.G., Fiske R. Failure of passive immunisation by colostrum from immunised mares to protect foals against Rhodococcus equi pneumonia. Equine Vet. J. 1991;23:19u201322. doi: 10.1111/j.2042-3306.1991.tb04752.x.
  23. Sturgill T.L., Horohov D.W. Vaccination response of young foals to keyhole limpet hemocyanin: Evidence of effective priming in the presence of maternal antibodies. J. Equine Vet. Sci. 2010;30:359u2013364. doi: 10.1016/j.jevs.2010.05.008.
  24. Ryan C, Giguu00e8re S. Equine neonates have attenuated humoral and cell-mediated immune responses to a killed adjuvanted vaccine compared to adult horses.. Clin Vaccine Immunol 2010 Dec;17(12):1896-902.
    doi: 10.1128/CVI.00328-10pmc: PMC3008191pubmed: 20943883google scholar: lookup
  25. Wilson WD, Mihalyi JE, Hussey S, Lunn DP. Passive transfer of maternal immunoglobulin isotype antibodies against tetanus and influenza and their effect on the response of foals to vaccination.. Equine Vet J 2001 Nov;33(7):644-50.
    doi: 10.2746/042516401776249435pubmed: 11770984google scholar: lookup
  26. Cullinane A, Weld J, Osborne M, Nelly M, Mcbride C, Walsh C. Field studies on equine influenza vaccination regimes in thoroughbred foals and yearlings.. Vet J 2001 Mar;161(2):174-85.
    doi: 10.1053/tvjl.2000.0546pubmed: 11243687google scholar: lookup
  27. Wilson W.D. Vaccination programs for goals and weanlings; Proceedings of the 45th Annual Convention; Albuquerque, NM, USA. 5u20138 December 1999; pp. 254u2013263.
  28. Muirhead TL, McClure JT, Wichtel JJ, Stryhn H, Markham RJ, McFarlane D, Lunn DP. The effect of age on the immune response of horses to vaccination.. J Comp Pathol 2010 Jan;142 Suppl 1:S85-90.
    doi: 10.1016/j.jcpa.2009.10.010pubmed: 19954792google scholar: lookup
  29. Muirhead TL, McClure JT, Wichtel JJ, Stryhn H, Frederick Markham RJ, McFarlane D, Lunn DP. The effect of age on serum antibody titers after rabies and influenza vaccination in healthy horses.. J Vet Intern Med 2008 May-Jun;22(3):654-61.
  30. McFarlane D. Equine pituitary pars intermedia dysfunction.. Vet Clin North Am Equine Pract 2011 Apr;27(1):93-113.
    doi: 10.1016/j.cveq.2010.12.007pubmed: 21392656google scholar: lookup
  31. Recknagel S., Snyder A., Brueser B., Schusser G.F. Immunization strategies and seroprotection against tetanus in horses in central Germany. Pferdeheilkunde. 2015;31:469u2013476. doi: 10.21836/PEM20150506.
    doi: 10.21836/PEM20150506google scholar: lookup
  32. Kay G., Souhail M., Mazan M. Recurrent tetanus in a donkey. Equine Vet. Educ. 2021 doi: 10.1111/eve.13580.
    doi: 10.1111/eve.13580google scholar: lookup
  33. Wilson W.D. Interpretation of Equine Laboratory Diagnostics. John Wiley & Sons; Hoboken, NJ, USA: 2017. Assessment of Vaccination Status and Susceptibility to Infection; p. 227.
  34. Kendall A, Anagrius K, Gu00e5nheim A, Rosanowski SM, Bergstru00f6m K. Duration of tetanus immunoglobulin G titres following basic immunisation of horses.. Equine Vet J 2016 Nov;48(6):710-713.
    doi: 10.1111/evj.12502pubmed: 26284567google scholar: lookup
  35. Lu00f6hrer J, Radvila P. [Active tetanus prevention in the horse and the duration of immunity].. Schweiz Arch Tierheilkd 1970 Jul;112(7):307-14.
    pubmed: 5516828
  36. Recknagel S, Snyder A, Blanke A, Uhlig A, Bru00fcser B, Schusser GF. [Evaluation of an immunochromatographic dipstick test for the assessment of tetanus immunity in horses].. Berl Munch Tierarztl Wochenschr 2015 Sep-Oct;128(9-10):376-83.
    pubmed: 26591383
  37. Green SL, Little CB, Baird JD, Tremblay RR, Smith-Maxie LL. Tetanus in the horse: a review of 20 cases (1970 to 1990).. J Vet Intern Med 1994 Mar-Apr;8(2):128-32.
  38. van Galen G, Saegerman C, Rijckaert J, Amory H, Armengou L, Bezdekova B, Durie I, Findshu00f8j Delany R, Fouchu00e9 N, Haley L, Hewetson M, van den Hoven R, Kendall A, Malalana F, Muller Cavalleri J, Picavet T, Roscher K, Verwilghen D, Wehrli Eser M, Westermann C, Mair T. Retrospective evaluation of 155 adult equids and 21 foals with tetanus in Western, Northern, and Central Europe (2000-2014). Part 1: Description of history and clinical evolution.. J Vet Emerg Crit Care (San Antonio) 2017 Nov;27(6):684-696.
    doi: 10.1111/vec.12668pubmed: 28960717google scholar: lookup
  39. Jansen BC, Knoetze PC. The immune response of horses to tetanus toxoid.. Onderstepoort J Vet Res 1979 Dec;46(4):211-6.
    pubmed: 551370
  40. Heldens JG, Pouwels HG, Derks CG, Van de Zande SM, Hoeijmakers MJ. Duration of immunity induced by an equine influenza and tetanus combination vaccine formulation adjuvanted with ISCOM-Matrix.. Vaccine 2010 Oct 8;28(43):6989-96.
    doi: 10.1016/j.vaccine.2010.08.043pubmed: 20728523google scholar: lookup
  41. Liefman CE. Combined active-passive immunisation of horses against tetanus.. Aust Vet J 1980 Mar;56(3):119-22.
  42. Harvey AM, Watson JL, Brault SA, Edman JM, Moore SM, Kass PH, Wilson WD. Duration of serum antibody response to rabies vaccination in horses.. J Am Vet Med Assoc 2016 Aug 15;249(4):411-8.
    doi: 10.2460/javma.249.4.411pubmed: 27479286google scholar: lookup
  43. Brown CM, Slavinski S, Ettestad P, Sidwa TJ, Sorhage FE. Compendium of Animal Rabies Prevention and Control, 2016.. J Am Vet Med Assoc 2016 Mar 1;248(5):505-17.
    doi: 10.2460/javma.248.5.505pubmed: 26885593google scholar: lookup
  44. Hooper DC, Morimoto K, Bette M, Weihe E, Koprowski H, Dietzschold B. Collaboration of antibody and inflammation in clearance of rabies virus from the central nervous system.. J Virol 1998 May;72(5):3711-9.
  45. Wiktor TJ, Doherty PC, Koprowski H. In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus.. Proc Natl Acad Sci U S A 1977 Jan;74(1):334-8.
    doi: 10.1073/pnas.74.1.334pmc: PMC393254pubmed: 299948google scholar: lookup
  46. Wiktor TJ, Doherty PC, Koprowski H. Suppression of cell-mediated immunity by street rabies virus.. J Exp Med 1977 Jun 1;145(6):1617-22.
    doi: 10.1084/jem.145.6.1617pmc: PMC2180689pubmed: 301176google scholar: lookup
  47. Fischer L, Minke J, Dufay N, Baudu P, Audonnet JC. Rabies DNA vaccine in the horse: strategies to improve serological responses.. Vaccine 2003 Nov 7;21(31):4593-6.
    doi: 10.1016/S0264-410X(03)00504-8pubmed: 14575772google scholar: lookup
  48. Green SL, Smith LL, Vernau W, Beacock SM. Rabies in horses: 21 cases (1970-1990).. J Am Vet Med Assoc 1992 Apr 15;200(8):1133-7.
    pubmed: 1607322
  49. Chappuis G. Neonatal immunity and immunisation in early age: lessons from veterinary medicine.. Vaccine 1998 Aug-Sep;16(14-15):1468-72.
  50. Chapman GE, Baylis M, Archer D, Daly JM. The challenges posed by equine arboviruses.. Equine Vet J 2018 Jul;50(4):436-445.
    doi: 10.1111/evj.12829pubmed: 29517814google scholar: lookup
  51. Chaintoutis SC, Diakakis N, Papanastassopoulou M, Banos G, Dovas CI. Evaluation of Cross-Protection of a Lineage 1 West Nile Virus Inactivated Vaccine against Natural Infections from a Virulent Lineage 2 Strain in Horses, under Field Conditions.. Clin Vaccine Immunol 2015 Sep;22(9):1040-9.
    doi: 10.1128/CVI.00302-15pmc: PMC4550672pubmed: 26178384google scholar: lookup
  52. Fehu00e9r O, Bakonyi T, Barna M, Nagy A, Taku00e1cs M, Szenci O, Jou00f3 K, Su00e1rdi S, Korbacska-Kutasi O. Serum neutralising antibody titres against a lineage 2 neuroinvasive West Nile Virus strain in response to vaccination with an inactivated lineage 1 vaccine in a European endemic area.. Vet Immunol Immunopathol 2020 Sep;227:110087.
    doi: 10.1016/j.vetimm.2020.110087pubmed: 32629300google scholar: lookup
  53. Minke JM, Siger L, Cupillard L, Powers B, Bakonyi T, Boyum S, Nowotny N, Bowen R. Protection provided by a recombinant ALVAC(u00ae)-WNV vaccine expressing the prM/E genes of a lineage 1 strain of WNV against a virulent challenge with a lineage 2 strain.. Vaccine 2011 Jun 20;29(28):4608-12.
    doi: 10.1016/j.vaccine.2011.04.058pubmed: 21549780google scholar: lookup
  54. Waldridge BM, Wenzel JG, Ellis AC, Rowe-Morton SE, Bridges ER, D'Andrea G, Wint R. Serologic responses to eastern and western equine encephalomyelitis vaccination in previously vaccinated horses.. Vet Ther 2003 Fall;4(3):242-8.
    pubmed: 15136985
  55. Gibbs E.P.J., Wilson J.H., All B. Proceedings of Equine Infectious Diseases V: Proceedings of the 5th International Conference. The University Press of Kentucky; Lexington, KY, USA: 1988. Studies on passive immunity and the vaccination of foals against eastern equine encephalitis in Florida; pp. 201u2013205.
  56. Calisher CH, Sasso DR, Sather GE. Possible evidence for interference with Venezuelan equine encephalitis virus vaccination of equines by pre-existing antibody to Eastern or Western Equine encephalitis virus, or both.. Appl Microbiol 1973 Oct;26(4):485-8.
    doi: 10.1128/am.26.4.485-488.1973pmc: PMC379832pubmed: 4751797google scholar: lookup
  57. Zacks MA, Paessler S. Encephalitic alphaviruses.. Vet Microbiol 2010 Jan 27;140(3-4):281-6.
  58. Walton TE, Jochim MM, Barber TL, Thompson LH. Cross-protective immunity between equine encephalomyelitis viruses in equids.. Am J Vet Res 1989 Sep;50(9):1442-6.
    pubmed: 2552875
  59. Barber TL, Walton TE, Lewis KJ. Efficacy of trivalent inactivated encephalomyelitis virus vaccine in horses.. Am J Vet Res 1978 Apr;39(4):621-5.
    pubmed: 646197
  60. Ferguson JA, Reeves WC, Hardy JL. Studies on immunity to alphaviruses in foals.. Am J Vet Res 1979 Jan;40(1):5-10.
    pubmed: 453684
  61. Khatibzadeh SM, Gold CB, Keggan AE, Perkins GA, Glaser AL, Dubovi EJ, Wagner B. West Nile virus-specific immunoglobulin isotype responses in vaccinated and infected horses.. Am J Vet Res 2015 Jan;76(1):92-100.
    doi: 10.2460/ajvr.76.1.92pubmed: 25535666google scholar: lookup
  62. Siger L, Bowen R, Karaca K, Murray M, Jagannatha S, Echols B, Nordgren R, Minke JM. Evaluation of the efficacy provided by a Recombinant Canarypox-Vectored Equine West Nile Virus vaccine against an experimental West Nile Virus intrathecal challenge in horses.. Vet Ther 2006 Fall;7(3):249-56.
    pubmed: 17039448
  63. Long MT, Gibbs EP, Mellencamp MW, Bowen RA, Seino KK, Zhang S, Beachboard SE, Humphrey PP. Efficacy, duration, and onset of immunogenicity of a West Nile virus vaccine, live Flavivirus chimera, in horses with a clinical disease challenge model.. Equine Vet J 2007 Nov;39(6):491-7.
    doi: 10.2746/042516407X217416pubmed: 18065305google scholar: lookup
  64. Siger L, Bowen RA, Karaca K, Murray MJ, Gordy PW, Loosmore SM, Audonnet JC, Nordgren RM, Minke JM. Assessment of the efficacy of a single dose of a recombinant vaccine against West Nile virus in response to natural challenge with West Nile virus-infected mosquitoes in horses.. Am J Vet Res 2004 Nov;65(11):1459-62.
    doi: 10.2460/ajvr.2004.65.1459pubmed: 15566080google scholar: lookup
  65. Davidson AH, Traub-Dargatz JL, Rodeheaver RM, Ostlund EN, Pedersen DD, Moorhead RG, Stricklin JB, Dewell RD, Roach SD, Long RE, Albers SJ, Callan RJ, Salman MD. Immunologic responses to West Nile virus in vaccinated and clinically affected horses.. J Am Vet Med Assoc 2005 Jan 15;226(2):240-5.
    doi: 10.2460/javma.2005.226.240pubmed: 15706975google scholar: lookup
  66. Ng T, Hathaway D, Jennings N, Champ D, Chiang YW, Chu HJ. Equine vaccine for West Nile virus.. Dev Biol (Basel) 2003;114:221-7.
    pubmed: 14677692
  67. Long MT, Jeter W, Hernandez J, Sellon DC, Gosche D, Gillis K, Bille E, Gibbs EP. Diagnostic performance of the equine IgM capture ELISA for serodiagnosis of West Nile virus infection.. J Vet Intern Med 2006 May-Jun;20(3):608-13.
  68. Long MT. West nile virus and equine encephalitis viruses: new perspectives.. Vet Clin North Am Equine Pract 2014 Dec;30(3):523-42.
    doi: 10.1016/j.cveq.2014.08.009pubmed: 25441112google scholar: lookup
  69. Long M., Porter M., Hernandez J., Giguere S., Fontaine G., Jodoin E., Gillis K. Preliminary data regarding the subclinical exposure rate of horses to West Nile virus during the 2001 Florida enzootic. Proc. Am. Assoc. Equine Pract. 2003;49:397u2013398.
  70. Durand B, Dauphin G, Zeller H, Labie J, Schuffenecker I, Murri S, Moutou F, Zientara S. Serosurvey for West Nile virus in horses in southern France.. Vet Rec 2005 Nov 26;157(22):711-3.
    doi: 10.1136/vr.157.22.711pubmed: 16311385google scholar: lookup
  71. Roehrig JT, Nash D, Maldin B, Labowitz A, Martin DA, Lanciotti RS, Campbell GL. Persistence of virus-reactive serum immunoglobulin m antibody in confirmed west nile virus encephalitis cases.. Emerg Infect Dis 2003 Mar;9(3):376-9.
    doi: 10.3201/eid0903.020531pmc: PMC2958550pubmed: 12643836google scholar: lookup
  72. Kitai Y, Shirafuji H, Kanehira K, Kamio T, Kondo T, Konishi E. Specific antibody responses to West Nile virus infections in horses preimmunized with inactivated Japanese encephalitis vaccine: evaluation of blocking enzyme-linked immunosorbent assay and complement-dependent cytotoxicity assay.. Vector Borne Zoonotic Dis 2011 Aug;11(8):1093-8.
    doi: 10.1089/vbz.2010.0094pubmed: 21254919google scholar: lookup
  73. Vest DJ, Cohen ND, Berezowski CJ, Morehead JP, Blodgett GP, Blanchard TL. Evaluation of administration of West Nile virus vaccine to pregnant broodmares.. J Am Vet Med Assoc 2004 Dec 15;225(12):1894-7.
    doi: 10.2460/javma.2004.225.1894pubmed: 15643840google scholar: lookup
  74. Wilkins PA, Glaser AL, McDonnell SM. Passive transfer of naturally acquired specific immunity against West Nile Virus to foals in a semi-feral pony herd.. J Vet Intern Med 2006 Jul-Aug;20(4):1045-7.
  75. Gardner IA, Wong SJ, Ferraro GL, Balasuriya UB, Hullinger PJ, Wilson WD, Shi PY, MacLachlan NJ. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California.. Vet Res 2007 Jan-Feb;38(1):109-16.
    doi: 10.1051/vetres:2006045pubmed: 17274156google scholar: lookup
  76. Boyle AG, Timoney JF, Newton JR, Hines MT, Waller AS, Buchanan BR. Streptococcus equi Infections in Horses: Guidelines for Treatment, Control, and Prevention of Strangles-Revised Consensus Statement.. J Vet Intern Med 2018 Mar;32(2):633-647.
    doi: 10.1111/jvim.15043pmc: PMC5867011pubmed: 29424487google scholar: lookup
  77. Andersen SA, Petersen HH, Ersbu00f8ll AK, Falk-Ru00f8nne J, Jacobsen S. Vaccination elicits a prominent acute phase response in horses.. Vet J 2012 Feb;191(2):199-202.
    doi: 10.1016/j.tvjl.2011.01.019pubmed: 21371917google scholar: lookup
  78. Arfuso F, Giudice E, Di Pietro S, Piccione G, Giannetto C. Modulation of Serum Protein Electrophoretic Pattern and Leukocyte Population in Horses Vaccinated against West Nile Virus.. Animals (Basel) 2021 Feb 11;11(2).
    doi: 10.3390/ani11020477pmc: PMC7918827pubmed: 33670395google scholar: lookup
  79. Holmes M., Townsend H., Hussey S., Breathnach C., Barnett C., Holland R., Lunn D. Immune responses to commercial equine vaccines; Proceedings of the 49th Annual Convention of the American Association of Equine Practitioners; New Orleans, LA, USA. 21u201325 November 2003; pp. 224u2013226.
  80. Holmes MA, Townsend HG, Kohler AK, Hussey S, Breathnach C, Barnett C, Holland R, Lunn DP. Immune responses to commercial equine vaccines against equine herpesvirus-1, equine influenza virus, eastern equine encephalomyelitis, and tetanus.. Vet Immunol Immunopathol 2006 May 15;111(1-2):67-80.
    doi: 10.1016/j.vetimm.2006.01.010pubmed: 16476488google scholar: lookup
  81. Cortese V., Hankins K., Holland R., Syvrud K. Serologic responses of West Nile virus seronegative mature horses to West Nile virus vaccines. J. Equine Vet. Sci. 2013;33:1101u20131105. doi: 10.1016/j.jevs.2013.04.010.
  82. Chapuis RJJ, Smith JS, French HM, Toka FN, Peterson EW, Little EL. Nonlinear Mixed-Effect Pharmacokinetic Modeling and Distribution of Doxycycline in Healthy Female Donkeys after Multiple Intragastric Dosing-Preliminary Investigation.. Animals (Basel) 2021 Jul 9;11(7).
    doi: 10.3390/ani11072047pmc: PMC8300337pubmed: 34359175google scholar: lookup
  83. Barrandeguy M.E., Carossino M. Infectious diseases in donkeys and mules: An overview and update. J. Equine Vet. Sci. 2018;65:98u2013105. doi: 10.1016/j.jevs.2018.02.026.
  84. Day MJ. The CALLISTO Project: A Summary.. J Comp Pathol 2016 Jul;155(1 Suppl 1):S1-7.
    doi: 10.1016/j.jcpa.2015.01.005pubmed: 25728814google scholar: lookup

Citations

This article has been cited 2 times.
  1. Kinoshita Y, Yamanaka T, Kodaira K, Niwa H, Uchida-Fujii E, Ueno T. Assessment of tetanus revaccination regimens in horses not vaccinated in the previous year.. J Vet Med Sci 2023 Jul 17;85(7):751-754.
    doi: 10.1292/jvms.23-0158pubmed: 37258221google scholar: lookup
  2. Carnet F, Perrin-Cocon L, Paillot R, Lotteau V, Pronost S, Vidalain PO. An inventory of adjuvants used for vaccination in horses: the past, the present and the future.. Vet Res 2023 Mar 2;54(1):18.
    doi: 10.1186/s13567-023-01151-3pubmed: 36864517google scholar: lookup